Vision
Vision, licence 80063777: active licence in Health Canada data. The French and European references below do not constitute authorisation for sale in France or an assessment of safety or efficacy.
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
Natural health product licensed in Canada
- Licence holder
- Idunn Technologies Inc.
- NPN or DIN-HM
- 80063777
- Status
- Active licence
- Licence date
- 2 September 2015
- Revision date
- Not provided
- Form
- Capsule
- Route of administration
- Orale
- Application type
- Non traditionnelle
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Tagetes erecta Source : Tagetes erecta - Fleur Extract : Matériel brut sec Extraction ratio : 15.000:1 Dry plant equivalent : 6000 milligramme Potency : 5.0 % Lutéine | 400.0 milligramme | Not calculated |
| Olea europaea Source : Olea europaea - Fruit Extract : Matériel brut frais Extraction ratio : 79.545:1 Dry plant equivalent : 3500 milligramme Potency : 12.0 % 3,4-dihydroxyphényléthanol | 44.0 milligramme | Not calculated |
| Zinc Source : Oxyde de zinc | 15.0 milligramme | 15,000 µg |
| Cuivre Source : Cuivre | 2.0 milligramme | 2,000 µg |
Non-medicinal ingredients
Cellulose, microcristalline, Stéarate de magnésium
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | 1.0 Capsule | 1.0 Tous les jours |
Uses authorised in Canada
Fournit des antioxydants. Aide à préserver la santé des yeux dans certaines conditions telles que les cataractes et la dégénérescence maculaire reliée à l'âge.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Précautions et mises en garde
Ne pas utiliser en cas d'allergie à la famille des Astéracées/Composées/Marguerites. Entreposer dans un contenant hermétiquement fermé, résistant à la lumière et à l'oxygène, dans un endroit frais et sec.
Source
Official Health Canada record, licence 80063777
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.